amyotrophic lateral sclerosis
Conditions
Interventions
"Opening and closing" acupuncture group:Acupuncture plus riluzole
control group: riluzole
Sponsors
The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1) meet the above diagnostic criteria; 2) Patients with amyotrophic lateral sclerosis health status Rating (ALS-HSS) of grade 1 to 3; 3) Time of onset < 2 years; 4) Age 18-70 years old; 5) Stable vital signs and normal coagulation function; 6) Good compliance, voluntarily accept acupuncture and cooperate with treatment, complete observation, and family members sign informed consent.
Exclusion criteria
Exclusion criteria: 1) Those who do not meet the above diagnostic and inclusion criteria; 2) Pregnant or lactating women, allergic or allergic to therapeutic drugs. 3) Patients with contraindications to acupuncture and moxibustion, complicated with serious primary diseases such as heart, liver, kidney, hematopoietic system, endocrine system and infectious or infectious diseases; Patients with bleeding tendencies or bleeding disorders; Patients with a history of fainting needles and fainting blood; Patients with severe aphasia, sleep apnea, deafness, severe cognitive impairment and inability to communicate normally; Or are participating in other clinical research trials; 4) Patients who refuse to sign informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ALSFRS-R; | — |
Secondary
| Measure | Time frame |
|---|---|
| SCr\UA\CK;PAC-QOL; | — |
Countries
the People's Republic of China
Contacts
Public ContactChuyun Chen
The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University
Outcome results
None listed